Marc J Kirchmeier

Title: The Innovations of Marc J Kirchmeier

Introduction

Marc J Kirchmeier is an accomplished inventor based in Harleysville, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. With a total of two patents to his name, Kirchmeier's work focuses on innovative methods and compositions that address viral infections.

Latest Patents

Kirchmeier's latest patents include "Methods and compositions for therapeutic agents" and "Compositions and methods for treating viral infections." The first patent provides compositions that comprise therapeutic agents, such as live attenuated viral antigens and therapeutic proteins, along with a lipid component. This lipid component may consist of various types of lipids. In some embodiments, the therapeutic agents are thermolabile. The patent also outlines methods for preparing these compositions, including melt methods and spray injection methods. The second patent focuses on immunogenic compositions that include an attenuated or inactivated virus combined with a non-ionic surfactant vesicle (NISV), which are useful for treating viral infections.

Career Highlights

Kirchmeier is currently associated with Variation Biotechnologies Inc., where he continues to innovate in the field of biotechnology. His work has the potential to significantly impact the treatment of viral infections, showcasing his dedication to advancing medical science.

Collaborations

Some of Kirchmeier's notable coworkers include David E Anderson and Tanvir Ahmed, who contribute to the collaborative efforts within their research environment.

Conclusion

Marc J Kirchmeier's contributions to biotechnology through his patents and work at Variation Biotechnologies Inc. highlight his role as a key innovator in developing therapeutic solutions for viral infections. His ongoing research promises to enhance the effectiveness of treatments in this critical area of health.